Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact
- PMID: 28611081
- DOI: 10.1136/annrheumdis-2017-211790
Umbilical cord mesenchymal stem cells for the treatment of autoimmune diseases: beware of cell-to-cell contact
Keywords: Autoimmunity; Systemic Lupus Erythematosus; Treatment.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'Umbilical-cord messenchymal stem cells for the treatment of automimmune diseases: beware of cell to cell contact' by Alunno et al.Ann Rheum Dis. 2018 Mar;77(3):e15. doi: 10.1136/annrheumdis-2017-211808. Epub 2017 Jun 29. Ann Rheum Dis. 2018. PMID: 28663307 No abstract available.
Comment on
-
A randomised double-blind, placebo-controlled trial of allogeneic umbilical cord-derived mesenchymal stem cell for lupus nephritis.Ann Rheum Dis. 2017 Aug;76(8):1436-1439. doi: 10.1136/annrheumdis-2017-211073. Epub 2017 May 6. Ann Rheum Dis. 2017. PMID: 28478399 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
